Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

27 Apr 2004

Abstract excerpt

High-grade ovarian serous papillary cancer (OSPC) and uterine serous papillary carcinoma (USPC) represent two histologically similar malignancies characterised by markedly different biological behavior and response to chemotherapy. Understanding the molecular basis of these differences may significantly refine differential diagnosis and management, and may lead to the development of novel, more specific and more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Galectins and Cancer Biology
Share to Ovarian cancer diagnosis and treatment
Share to Reproductive System and Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15208622
DOI: 10.1038/sj.bjc.6601791

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profilingPMID 15208622Read ↗

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapySemantic proximity Read ↗

Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusionsSemantic proximity Read ↗

Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal MesotheliomaSemantic proximity Read ↗

Efficient molecular subtype classification of high‐grade serous ovarian cancerSemantic proximity Read ↗

Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian CancerSemantic proximity Read ↗

The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancerSemantic proximity Read ↗

Expression Profiling of Serous Low Malignant Potential, Low-Grade, and High-Grade Tumors of the OvarySemantic proximity Read ↗

Differential Protein Mapping of Ovarian Serous Adenocarcinomas: Identification of Potential Markers for Distinct Tumor StageSemantic proximity Read ↗

Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomasSemantic proximity Read ↗

An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian CarcinomaSemantic proximity Read ↗

cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.Semantic proximity Read ↗

Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.